1.1M XNAS Volume
XNAS 04 Apr, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Stuart Naylor | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 50,000 | 50,000 | - | - | Restricted Share Units | |
| Stuart Naylor | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 50,000 | 646,791 (1%) | 0% | - | Ordinary Shares | |
| Stuart Naylor | CHIEF DEV. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.30 per share. | 21 Feb 2025 | 23,500 | 623,291 (1%) | 0% | 7.3 | 171,550 | Ordinary Shares |
| Alexandria Forbes | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 125,000 | 1,522,578 (4%) | 0% | - | Ordinary Shares | |
| Alexandria Forbes | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 125,000 | 125,000 | - | - | Restricted Share Units | |
| Alexandria Forbes | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.30 per share. | 21 Feb 2025 | 66,095 | 1,456,483 (3%) | 0% | 7.3 | 482,494 | Ordinary Shares |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.30 per share. | 21 Feb 2025 | 5,903 | 136,520 (0%) | 0% | 7.3 | 43,092 | Ordinary Shares |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 15,000 | 142,423 (0%) | 0% | - | Ordinary Shares | |
| Richard Giroux | CFO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.30 per share. | 21 Feb 2025 | 63,452 | 906,495 (2%) | 0% | 7.3 | 463,200 | Ordinary Shares |
| Richard Giroux | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 120,000 | 969,947 (2%) | 0% | - | Ordinary Shares | |
| Richard Giroux | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 120,000 | 120,000 | - | - | Restricted Share Units | |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 22,500 | 43,262 (0%) | 0% | - | Ordinary Shares | |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.30 per share. | 21 Feb 2025 | 12,116 | 31,146 (0%) | 0% | 7.3 | 88,447 | Ordinary Shares |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 22,500 | 22,500 | - | - | Restricted Share Units | |
| Richard Giroux | CFO & COO | Sale of securities on an exchange or to another person at price $ 6.29 per share. | 21 Jan 2025 | 24,000 | 849,947 (2%) | 0% | 6.3 | 150,960 | Ordinary Shares |
| Stuart Naylor | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 23,750 | 607,954 (1%) | 0% | - | Ordinary Shares | |
| Stuart Naylor | CHIEF DEV. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.77 per share. | 14 Jan 2025 | 11,163 | 596,791 (1%) | 0% | 5.8 | 64,411 | Ordinary Shares |
| Stuart Naylor | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 23,750 | 0 | - | - | Restricted Share Units | |
| Alexandria Forbes | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.77 per share. | 14 Jan 2025 | 15,863 | 1,397,578 (3%) | 0% | 5.8 | 91,530 | Ordinary Shares |
| Alexandria Forbes | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 30,000 | 0 | - | - | Restricted Share Units | |
| Alexandria Forbes | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 30,000 | 1,413,441 (3%) | 0% | - | Ordinary Shares | |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 37,500 | 142,572 (0%) | 0% | - | Ordinary Shares | |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 37,500 | 0 | - | - | Restricted Share Units | |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.77 per share. | 14 Jan 2025 | 15,149 | 127,423 (0%) | 0% | 5.8 | 87,410 | Ordinary Shares |
| Richard Giroux | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 25,000 | 887,166 (2%) | 0% | - | Ordinary Shares | |
| Richard Giroux | CFO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.77 per share. | 14 Jan 2025 | 13,219 | 873,947 (2%) | 0% | 5.8 | 76,274 | Ordinary Shares |
| Richard Giroux | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 25,000 | 0 | - | - | Restricted Share Units | |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 5,000 | 23,671 (0%) | 0% | - | Ordinary Shares | |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.77 per share. | 14 Jan 2025 | 2,909 | 20,762 (0%) | 0% | 5.8 | 16,785 | Ordinary Shares |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 5,000 | 0 | - | - | Restricted Share Units | |
| Thomas E. Shenk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 45,000 | - | - | Restricted Share Units | |
| Nicole Seligman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 45,000 | - | - | Restricted Share Units | |
| Ellen Hukkelhoven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 45,000 | - | - | Restricted Share Units | |
| Neil Mendoza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 45,000 | - | - | Restricted Share Units | |
| Debra Yu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 45,000 | - | - | Restricted Share Units | |
| Keith R. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 75,000 | 75,000 | - | - | Restricted Share Units | |
| Keith R. Harris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 30,000 | 0 | - | - | Restricted Share Units | |
| Keith R. Harris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 30,000 | 50,000 (0%) | 0% | - | Ordinary Shares | |
| Martin Indyk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 20,000 | 0 | - | - | Restricted Share Units | |
| Martin Indyk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 45,000 | 45,000 | - | - | Restricted Share Units | |
| Martin Indyk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 20,000 | 35,000 (0%) | 0% | - | Ordinary Shares | |
| Richard Giroux | CFO & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 28 May 2024 | 3,000 | 837,426 (2%) | 0% | 0 | Ordinary Shares | |
| Alexandria Forbes | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Apr 2024 | 1,000 | 1,372,504 (3%) | 0% | 0 | Ordinary Shares | |
| Alexandria Forbes | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Mar 2024 | 2,000 | 1,373,504 (3%) | 0% | 0 | Ordinary Shares | |
| Richard Giroux | CFO & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Feb 2024 | 13,500 | 840,426 (2%) | 0% | 0 | Ordinary Shares | |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.36 per share. | 14 Jan 2024 | 2,644 | 15,137 (0%) | 0% | 6.4 | 16,816 | Ordinary Shares |
| Giroux Richard | CFO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.36 per share. | 14 Jan 2024 | 13,219 | 853,926 (2%) | 0% | 6.4 | 84,073 | Ordinary Shares |
| K. Robert Zeldin | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Richard Giroux | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2024 | 25,000 | 867,145 (2%) | 0% | - | Ordinary Shares | |
| Naylor Stuart | CHIEF DEV. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.36 per share. | 14 Jan 2024 | 11,163 | 564,329 (1%) | 0% | 6.4 | 70,997 | Ordinary Shares |
| Stuart Naylor | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2024 | 23,750 | 23,750 | - | - | Restricted Share Units | |
| K. Zeldin Robert | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2024 | 37,500 | 37,500 | - | - | Restricted Share Units | |
| Forbes Alexandria | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2024 | 620,000 | 620,000 | - | - | Restricted Share Units | |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2024 | 5,000 | 17,781 (0%) | 0% | - | Ordinary Shares | |
| Forbes Alexandria | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.36 per share. | 14 Jan 2024 | 15,863 | 1,375,504 (3%) | 0% | 6.4 | 100,889 | Ordinary Shares |
| Robert Zeldin K. | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2024 | 70,000 | 70,000 | - | - | Restricted Share Units | |
| Wollin Robert J. | GENERAL COUNSEL AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2024 | 5,000 | 5,000 | - | - | Restricted Share Units | |
| Richard Giroux | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2024 | 25,000 | 25,000 | - | - | Restricted Share Units | |
| Forbes Alexandria | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2024 | 30,000 | 30,000 | - | - | Restricted Share Units | |
| Naylor Stuart | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2024 | 23,750 | 575,492 (1%) | 0% | - | Ordinary Shares | |
| Giroux Richard | CFO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2024 | 620,000 | 620,000 | - | - | Restricted Share Units | |
| Alexandria Forbes | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2024 | 30,000 | 1,391,367 (3%) | 0% | - | Ordinary Shares | |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.36 per share. | 14 Jan 2024 | 14,756 | 89,724 (0%) | 0% | 6.4 | 93,848 | Ordinary Shares |
| Stuart Naylor | CHIEF DEV. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2024 | 150,000 | 150,000 | - | - | Restricted Share Units | |
| K. Robert Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2024 | 37,500 | 104,480 (0%) | 0% | - | Ordinary Shares | |
| Wollin Robert J. | GENERAL COUNSEL AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2024 | 100,000 | 100,000 | - | - | Restricted Share Units | |
| Forbes Alexandria | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2024 | 48,750 | 0 | - | - | Restricted Share Units | |
| Robert Zeldin K. | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.30 per share. | 07 Jan 2024 | 13,773 | 71,714 (0%) | 0% | 6.3 | 86,770 | Ordinary Shares |
| Giroux Richard | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2024 | 105,000 | 105,000 | - | - | Restricted Share Units | |
| Forbes Alexandria | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.30 per share. | 07 Jan 2024 | 66,095 | 1,338,394 (3%) | 0% | 6.3 | 416,399 | Ordinary Shares |
| Forbes Alexandria | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2024 | 125,000 | 1,404,489 (3%) | 0% | - | Ordinary Shares | |
| Naylor Stuart | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2024 | 75,000 | 565,792 (1%) | 0% | - | Ordinary Shares | |
| Forbes Alexandria | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.63 per share. | 07 Jan 2024 | 25,777 | 1,361,367 (3%) | 0% | 6.6 | 170,902 | Ordinary Shares |
| Naylor Stuart | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2024 | 40,000 | 570,542 (1%) | 0% | - | Ordinary Shares | |
| Stuart Naylor | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2024 | 40,000 | 0 | - | - | Restricted Share Units | |
| Giroux Richard | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2024 | 37,500 | 0 | - | - | Restricted Share Units | |
| Stuart Naylor | CHIEF DEV. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.30 per share. | 07 Jan 2024 | 35,250 | 530,542 (1%) | 0% | 6.3 | 222,075 | Ordinary Shares |
| Naylor Stuart | CHIEF DEV. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.63 per share. | 07 Jan 2024 | 18,800 | 551,742 (1%) | 0% | 6.6 | 124,644 | Ordinary Shares |
| J. Wollin Robert | GENERAL COUNSEL AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2024 | 15,000 | 20,712 (0%) | 0% | - | Ordinary Shares | |
| Giroux Richard | CFO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.63 per share. | 07 Jan 2024 | 19,829 | 842,145 (2%) | 0% | 6.6 | 131,466 | Ordinary Shares |
| Richard Giroux | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2024 | 105,000 | 879,994 (2%) | 0% | - | Ordinary Shares | |
| Giroux Richard | CFO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.30 per share. | 07 Jan 2024 | 55,520 | 824,474 (2%) | 0% | 6.3 | 349,776 | Ordinary Shares |
| Alexandria Forbes | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2024 | 48,750 | 1,387,144 (3%) | 0% | - | Ordinary Shares | |
| Alexandria Forbes | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2024 | 125,000 | 125,000 | - | - | Restricted Share Units | |
| Giroux Richard | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2024 | 37,500 | 861,974 (2%) | 0% | - | Ordinary Shares | |
| Robert Wollin J. | GENERAL COUNSEL AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2024 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| J. Wollin Robert | GENERAL COUNSEL AND SECRETARY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.30 per share. | 07 Jan 2024 | 7,931 | 12,781 (0%) | 0% | 6.3 | 49,965 | Ordinary Shares |
| Naylor Stuart | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2024 | 75,000 | 75,000 | - | - | Restricted Share Units | |
| Thomas E. Shenk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 20,000 | 20,000 | - | - | Restricted Share Units | |
| Thomas E. Shenk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Nicole Seligman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Nicole Seligman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 22,500 | 22,500 | - | - | Restricted Share Units | |
| Ellen Hukkelhoven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Ellen Hukkelhoven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 20,000 | 20,000 | - | - | Restricted Share Units | |
| Neil Mendoza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 20,000 | 20,000 | - | - | Restricted Share Units | |
| Neil Mendoza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Debra Yu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Debra Yu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 20,000 | 20,000 | - | - | Restricted Share Units | |
| Keith R. Harris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 20,000 | 0 | - | - | Restricted Share Units | |
| Keith R. Harris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 20,000 | 20,000 (0%) | 0% | - | Ordinary Shares | |
| Keith R. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Keith R. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 30,000 | 30,000 | - | - | Restricted Share Units | |
| Martin Indyk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Martin Indyk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 20,000 | 20,000 | - | - | Restricted Share Units | |
| Martin Indyk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 15,000 | 0 | - | - | Restricted Share Units | |
| Martin Indyk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 15,000 | 15,000 (0%) | 0% | - | Ordinary Shares | |
| Stuart Naylor | CHIEF DEV. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 100,000 | 100,000 | - | - | Restricted Share Units | |
| Stuart Naylor | CHIEF DEV. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Alexandria Forbes | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Alexandria Forbes | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 250,000 | 250,000 | - | - | Restricted Share Units | |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 30,000 | 30,000 | - | - | Restricted Share Units | |
| Richard Giroux | CFO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | |
| Richard Giroux | CFO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 240,000 | 240,000 | - | - | Restricted Share Units | |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 45,000 | 45,000 | - | - | Restricted Share Units | |
| Stuart Naylor | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2023 | 47,500 | 513,117 (1%) | 0% | - | Ordinary Shares | |
| Stuart Naylor | CHIEF DEV. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.99 per share. | 14 Jan 2023 | 22,325 | 490,792 (1%) | 0% | 7.0 | 156,052 | Ordinary Shares |
| Stuart Naylor | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2023 | 47,500 | 47,500 | - | - | Restricted Share Units | |
| Alexandria Forbes | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2023 | 60,000 | 1,138,176 (3%) | 0% | - | Ordinary Shares | |
| Alexandria Forbes | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.99 per share. | 14 Jan 2023 | 31,726 | 1,106,450 (3%) | 0% | 7.0 | 221,765 | Ordinary Shares |
| Alexandria Forbes | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2023 | 60,000 | 60,000 | - | - | Restricted Share Units | |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2023 | 75,000 | 80,000 (0%) | 0% | - | Ordinary Shares | |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.99 per share. | 14 Jan 2023 | 29,513 | 50,487 (0%) | 0% | 7.0 | 206,296 | Ordinary Shares |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2023 | 75,000 | 75,000 | - | - | Restricted Share Units | |
| Richard Giroux | CFO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.99 per share. | 14 Jan 2023 | 26,438 | 774,994 (2%) | 0% | 7.0 | 184,802 | Ordinary Shares |
| Richard Giroux | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2023 | 50,000 | 801,432 (2%) | 0% | - | Ordinary Shares | |
| Richard Giroux | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2023 | 50,000 | 50,000 | - | - | Restricted Share Units | |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2023 | 10,000 | 10,000 | - | - | Restricted Share Units | |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.99 per share. | 14 Jan 2023 | 5,288 | 5,712 (0%) | 0% | 7.0 | 36,963 | Ordinary Shares |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2023 | 10,000 | 11,000 (0%) | 0% | - | Ordinary Shares | |
| Stuart Naylor | CHIEF DEV. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.60 per share. | 08 Jan 2023 | 18,800 | 465,617 (1%) | 0% | 6.6 | 124,080 | Ordinary Shares |
| Stuart Naylor | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2023 | 40,000 | 40,000 | - | - | Restricted Share Units | |
| Stuart Naylor | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2023 | 40,000 | 484,417 (1%) | 0% | - | Ordinary Shares | |
| Alexandria Forbes | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.60 per share. | 08 Jan 2023 | 25,777 | 1,078,176 (2%) | 0% | 6.6 | 170,128 | Ordinary Shares |
| Alexandria Forbes | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2023 | 48,750 | 48,750 | - | - | Restricted Share Units | |
| Alexandria Forbes | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2023 | 48,750 | 1,103,953 (3%) | 0% | - | Ordinary Shares | |
| Richard Giroux | CFO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.60 per share. | 08 Jan 2023 | 19,829 | 751,432 (2%) | 0% | 6.6 | 130,871 | Ordinary Shares |
| Richard Giroux | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2023 | 37,500 | 771,261 (2%) | 0% | - | Ordinary Shares | |
| Richard Giroux | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2023 | 37,500 | 37,500 | - | - | Restricted Share Units | |
| Alexandria Forbes | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 2,000 | 1,055,203 (2%) | 0% | 0 | Ordinary Shares | |
| Richard Giroux | CFO & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 5,500 | 733,761 (2%) | 0% | 0 | Ordinary Shares | |
| Richard Giroux | CFO & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 100,000 | 739,261 (2%) | 0% | 0 | Ordinary Shares | |
| Richard Giroux | CFO & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 9,000 | 839,261 (2%) | 0% | 0 | Ordinary Shares | |
| Richard Giroux | CFO & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 400 | 848,261 (2%) | 0% | 0 | Ordinary Shares | |
| Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Thomas E. Shenk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Thomas E. Shenk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Nicole Seligman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Nicole Seligman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Keith Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 20,000 | 20,000 | - | - | Restricted Share Units | |
| Keith Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Ellen Hukkelhoven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Ellen Hukkelhoven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Neil Mendoza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Neil Mendoza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Martin Indyk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Martin Indyk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | Purchase of securities on an exchange or from another person at price $ 7.83 per share. | 03 Jun 2022 | 6 | 5,000 (0%) | 0% | 7.8 | 47 | Ordinary Shares |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | Purchase of securities on an exchange or from another person at price $ 7.90 per share. | 03 Jun 2022 | 4,994 | 4,994 (0%) | 0% | 7.9 | 39,453 | Ordinary Shares |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Purchase of securities on an exchange or from another person at price $ 7.94 per share. | 25 May 2022 | 1,000 | 1,000 (0%) | 0% | 7.9 | 7,940 | Ordinary Shares |
| Debra Yu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Stuart Naylor | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2022 | 80,000 | 482,017 (1%) | 0% | - | Ordinary Shares | |
| Stuart Naylor | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.53 per share. | 07 Jan 2022 | 37,600 | 444,417 (1%) | 0% | 21.5 | 809,528 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 150,000 | 150,000 | - | - | Restricted Share Units | |
| Stuart Naylor | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2022 | 80,000 | 80,000 | - | - | Restricted Share Units | |
| Alexandria Forbes | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.53 per share. | 07 Jan 2022 | 51,554 | 1,109,227 (3%) | 0% | 21.5 | 1,109,958 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2022 | 97,500 | 1,160,781 (3%) | 0% | - | Ordinary Shares | |
| Alexandria Forbes | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2022 | 97,500 | 97,500 | - | - | Restricted Share Units | |
| Alexandria Forbes | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 250,000 | 250,000 | - | - | Restricted Share Units | |
| Robert K. Zeldin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 70,000 | 70,000 | - | - | Restricted Share Units | |
| Robert K. Zeldin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Richard Giroux | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2022 | 75,000 | 888,318 (2%) | 0% | - | Ordinary Shares | |
| Richard Giroux | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2022 | 75,000 | 75,000 | - | - | Restricted Share Units | |
| Richard Giroux | CFO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 210,000 | 210,000 | - | - | Restricted Share Units | |
| Richard Giroux | CFO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.53 per share. | 07 Jan 2022 | 39,657 | 848,661 (2%) | 0% | 21.5 | 853,815 | Ordinary Shares |
| Robert J. Wollin | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 30,000 | 30,000 | - | - | Restricted Share Units | |
| Robert J. Wollin | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 19.86 per share. | 16 Nov 2021 | 15,000 | 1,080,781 (2%) | 0% | 19.9 | 297,900 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.53 per share. | 16 Nov 2021 | 3,200 | 1,095,781 (2%) | 0% | 20.5 | 65,696 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 19.82 per share. | 16 Nov 2021 | 11,800 | 1,098,981 (3%) | 0% | 19.8 | 233,876 | Ordinary Shares |
| Richard Giroux | CFO & COO | Sale of securities on an exchange or to another person at price $ 21.28 per share. | 19 Oct 2021 | 6,956 | 819,218 (2%) | 0% | 21.3 | 148,024 | Ordinary Shares |
| Richard Giroux | CFO & COO | Sale of securities on an exchange or to another person at price $ 20.07 per share. | 19 Oct 2021 | 1,300 | 839,918 (2%) | 0% | 20.1 | 26,091 | Ordinary Shares |
| Richard Giroux | CFO & COO | Sale of securities on an exchange or to another person at price $ 20.93 per share. | 19 Oct 2021 | 13,744 | 826,174 (2%) | 0% | 20.9 | 287,662 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 17.95 per share. | 18 Oct 2021 | 12,000 | 402,017 (1%) | 0% | 18.0 | 215,400 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 17.92 per share. | 18 Oct 2021 | 6,179 | 1,110,781 (3%) | 0% | 17.9 | 110,728 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 17.21 per share. | 18 Oct 2021 | 23,821 | 1,116,960 (3%) | 0% | 17.2 | 409,959 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.06 per share. | 20 Jul 2021 | 9,390 | 414,017 (1%) | 0% | 15.1 | 141,413 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 13 Jul 2021 | 2,610 | 423,407 (1%) | 0% | 15.0 | 39,254 | Ordinary Shares |
| Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Thomas E. Shenk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Thomas E. Shenk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Nicole Seligman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Nicole Seligman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Keith Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 20,000 | 20,000 | - | - | Restricted Share Units | |
| Keith Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Ellen Hukkelhoven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Ellen Hukkelhoven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Neil Mendoza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Neil Mendoza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Martin Indyk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Martin Indyk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 07 Jun 2021 | 5,040 | 426,017 (1%) | 0% | 15.0 | 75,650 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.02 per share. | 07 Jun 2021 | 1,042 | 431,057 (1%) | 0% | 15.0 | 15,651 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2021 | 1,000 | 1,320,781 (3%) | 0% | 0 | Orindary Shares | |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.02 per share. | 07 Jun 2021 | 20,180 | 1,294,934 (3%) | 0% | 15.0 | 303,104 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 07 Jun 2021 | 4,153 | 1,290,781 (3%) | 0% | 15.0 | 62,461 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.03 per share. | 07 Jun 2021 | 5,667 | 1,315,114 (3%) | 0% | 15.0 | 85,175 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.14 per share. | 28 Apr 2021 | 3,772 | 434,245 (1%) | 0% | 15.1 | 57,108 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.02 per share. | 28 Apr 2021 | 1,405 | 432,840 (1%) | 0% | 15.0 | 21,103 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 28 Apr 2021 | 741 | 432,099 (1%) | 0% | 15.0 | 11,122 | Ordinary Shares |
| Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 12,882 | 0 | - | - | Stock Option (right to buy) | |
| Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.72 per share. | 15 Mar 2021 | 12,882 | 12,882 (0%) | 0% | 7.7 | 99,449 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.60 per share. | 16 Feb 2021 | 15,000 | 1,336,781 (3%) | 0% | 15.6 | 234,000 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.57 per share. | 16 Feb 2021 | 15,000 | 1,321,781 (3%) | 0% | 15.6 | 233,550 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2021 | 95,000 | 95,000 | - | - | Restricted Share Units | |
| Stuart Naylor | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2021 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Alexandria Forbes | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2021 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Alexandria Forbes | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2021 | 120,000 | 120,000 | - | - | Restricted Share Units | |
| Robert K. Zeldin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Robert K. Zeldin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2021 | 150,000 | 150,000 | - | - | Restricted Share Units | |
| Richard Giroux | CFO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2021 | 100,000 | 100,000 | - | - | Restricted Share Units | |
| Richard Giroux | CFO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Robert J. Wollin | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2021 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Robert J. Wollin | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2021 | 20,000 | 20,000 | - | - | Restricted Share Units | |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.34 per share. | 04 Jan 2021 | 6,000 | 438,017 (1%) | 0% | 15.3 | 92,040 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.40 per share. | 04 Jan 2021 | 6,000 | 444,017 (1%) | 0% | 15.4 | 92,400 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 17 Dec 2020 | 13,390 | 1,355,781 (3%) | 0% | 15 | 200,850 | Ordinary Shares |
| Richard Giroux | CFO & COO | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 17 Dec 2020 | 18,000 | 846,518 (2%) | 0% | 16 | 288,000 | Ordinary Shares |
| Richard Giroux | CFO & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2020 | 200,000 | 864,518 (2%) | 0% | 0 | Ordinary Shares | |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.17 per share. | 17 Nov 2020 | 15,000 | 1,370,781 (3%) | 0% | 15.2 | 227,550 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.05 per share. | 17 Nov 2020 | 1,610 | 1,369,171 (3%) | 0% | 15.1 | 24,231 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 10 Nov 2020 | 3,739 | 451,129 (1%) | 0% | 15 | 56,085 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.02 per share. | 10 Nov 2020 | 2,698 | 1,394,672 (3%) | 0% | 15.0 | 40,524 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.05 per share. | 10 Nov 2020 | 14,430 | 1,397,370 (3%) | 0% | 15.1 | 217,172 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 10 Nov 2020 | 8,891 | 1,385,781 (3%) | 0% | 15.0 | 133,454 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 05 Nov 2020 | 512 | 454,868 (1%) | 0% | 15 | 7,680 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.02 per share. | 05 Nov 2020 | 8,282 | 455,380 (1%) | 0% | 15.0 | 124,396 | Ordinary Shares |
| Alexandria Forbes | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Nov 2020 | 2,300 | 1,415,781 (3%) | 0% | 0 | Ordinary Shares | |
| Alexandria Forbes | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.03 per share. | 05 Nov 2020 | 3,981 | 1,411,800 (3%) | 0% | 15.0 | 59,834 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 05 Oct 2020 | 301 | 463,662 (1%) | 0% | 15 | 4,515 | Ordinary Shares |
| Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.63 per share. | 10 Aug 2020 | 15,459 | 15,459 (0%) | 0% | 5.6 | 87,034 | Ordinary Shares |
| Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2020 | 15,459 | 0 | - | - | Stock Option (right to buy) | |
| Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 14.15 per share. | 10 Aug 2020 | 7,959 | 0 (0%) | 0% | 14.2 | 112,620 | Ordinary Shares |
| Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 13.86 per share. | 10 Aug 2020 | 7,500 | 7,959 (0%) | 0% | 13.9 | 103,950 | Ordinary Shares |
| Thomas E. Shenk | Director | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 20 Jul 2020 | 6,667 | 157,476 (0%) | 0% | 15 | 100,005 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 20 Jul 2020 | 2,356 | 471,661 (1%) | 0% | 15 | 35,340 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 20 Jul 2020 | 7,698 | 463,963 (1%) | 0% | 15.0 | 115,778 | Ordinary Shares |
| Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2020 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2020 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Thomas E. Shenk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2020 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Nicole Seligman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2020 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Keith Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2020 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Ellen Hukkelhoven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2020 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Neil Mendoza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2020 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Martin Indyk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2020 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Alexandria Forbes | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 15.18 per share. | 20 May 2020 | 9,125 | 1,418,081 (3%) | 0% | 15.2 | 138,518 | Ordinary Shares |
| Alexandria Forbes | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 15.18 per share. | 20 May 2020 | 14,732 | 1,427,206 (3%) | 0% | 15.2 | 223,632 | Ordinary Shares |
| Alexandria Forbes | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 20 May 2020 | 6,143 | 1,441,938 (3%) | 0% | 15.0 | 92,391 | Ordinary Shares |
| Richard Giroux | CFO & COO | Sale of securities on an exchange or to another person at price $ 15.16 per share. | 20 May 2020 | 11,786 | 1,064,518 (2%) | 0% | 15.2 | 178,676 | Ordinary Shares |
| Richard Giroux | CFO & COO | Sale of securities on an exchange or to another person at price $ 15.03 per share. | 20 May 2020 | 6,143 | 1,076,304 (2%) | 0% | 15.0 | 92,329 | Ordinary Shares |
| Richard Giroux | CFO & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 May 2020 | 350 | 1,167,518 (3%) | 0% | 0 | Ordinary Shares | |
| Richard Giroux | CFO & COO | Sale of securities on an exchange or to another person at price $ 15.38 per share. | 13 May 2020 | 71 | 1,082,447 (2%) | 0% | 15.4 | 1,092 | Ordinary Shares |
| Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 15.77 per share. | 12 May 2020 | 4,900 | 75,022 (0%) | 0% | 15.8 | 77,273 | Ordinary Shares |
| Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 12 May 2020 | 22 | 75,000 (0%) | 0% | 15.8 | 348 | Ordinary Shares |
| Thomas E. Shenk | Director | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 11 May 2020 | 2,184 | 164,143 (0%) | 0% | 15 | 32,760 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.39 per share. | 11 May 2020 | 11,304 | 474,017 (1%) | 0% | 15.4 | 173,969 | Ordinary Shares |
| Thomas E. Shenk | Director | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 20 Apr 2020 | 4,482 | 166,327 (0%) | 0% | 15 | 67,230 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 20 Apr 2020 | 696 | 485,321 (1%) | 0% | 15 | 10,440 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 18.30 per share. | 18 Feb 2020 | 5,831 | 492,186 (1%) | 0% | 18.3 | 106,707 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 17.60 per share. | 18 Feb 2020 | 6,000 | 486,017 (1%) | 0% | 17.6 | 105,600 | Ordinary Shares |
| Stuart Naylor | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 18.96 per share. | 18 Feb 2020 | 169 | 492,017 (1%) | 0% | 19.0 | 3,204 | Ordinary Shares |
| Alexandria Forbes | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 17.35 per share. | 28 Jan 2020 | 14,861 | 1,463,220 (4%) | 0% | 17.3 | 257,838 | Ordinary Shares |
| Alexandria Forbes | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 17.77 per share. | 28 Jan 2020 | 15,000 | 1,448,081 (3%) | 0% | 17.8 | 266,550 | Ordinary Shares |
| Alexandria Forbes | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 17.91 per share. | 28 Jan 2020 | 139 | 1,463,081 (4%) | 0% | 17.9 | 2,489 | Ordinary Shares |
| Alexandria Forbes | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Jan 2020 | 5,000 | 1,478,081 (4%) | 0% | 0 | Ordinary Shares | |
| Richard Giroux | CFO & COO | Sale of securities on an exchange or to another person at price $ 19.51 per share. | 21 Jan 2020 | 8,498 | 1,177,370 (3%) | 0% | 19.5 | 165,796 | Ordinary Shares |
| Richard Giroux | CFO & COO | Sale of securities on an exchange or to another person at price $ 19.34 per share. | 21 Jan 2020 | 9,000 | 1,167,868 (3%) | 0% | 19.3 | 174,060 | Ordinary Shares |
| Richard Giroux | CFO & COO | Sale of securities on an exchange or to another person at price $ 20.32 per share. | 21 Jan 2020 | 502 | 1,176,868 (3%) | 0% | 20.3 | 10,201 | Ordinary Shares |
| Richard Giroux | CFO & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Jan 2020 | 1,000 | 1,185,868 (3%) | 0% | 0 | Ordinary Shares | |
| Stuart Naylor | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2020 | 160,000 | 160,000 | - | - | Restricted Share Units | |
| Alexandria Forbes | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2020 | 195,000 | 195,000 | - | - | Restricted Share Units | |
| Richard Giroux | CFO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2020 | 150,000 | 150,000 | - | - | Restricted Share Units | |
| Nicole Seligman | None | Purchase of securities on an exchange or from another person at price $ 16.31 per share. | 19 Nov 2019 | 5,000 | 5,000 (0%) | 0% | 16.3 | 81,550 | Ordinary Shares |
| Arnold J. Levine | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Joel S. Marcus | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Thomas E. Shenk | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Keith Harris | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Ellen Hukkelhoven | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Neil Mendoza | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Nicole Seligman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2019 | 50,000 | 50,000 | - | - | Stock Option | |
| Bruce Gottlieb | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2019 | 200,000 | 200,000 | - | - | Stock Option | |
| Martin Indyk | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2019 | 50,000 | 50,000 | - | - | Stock Option | |
| Stuart Naylor | Director, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2018 | 100,000 | 100,000 | - | - | Stock Option | |
| Alexandria Forbes | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2018 | 130,000 | 130,000 | - | - | Stock Option | |
| Richard Giroux | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2018 | 105,000 | 105,000 | - | - | Stock Option | |
| Katherine Breedis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2018 | 10,000 | 10,000 | - | - | Stock Option | |
| Katherine Breedis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2018 | 40,000 | 40,000 | - | - | Stock Option |